HK1203943A1 - Quinazolinedione derivative - Google Patents

Quinazolinedione derivative

Info

Publication number
HK1203943A1
HK1203943A1 HK15104398.3A HK15104398A HK1203943A1 HK 1203943 A1 HK1203943 A1 HK 1203943A1 HK 15104398 A HK15104398 A HK 15104398A HK 1203943 A1 HK1203943 A1 HK 1203943A1
Authority
HK
Hong Kong
Prior art keywords
quinazolinedione derivative
quinazolinedione
derivative
Prior art date
Application number
HK15104398.3A
Other languages
English (en)
Chinese (zh)
Inventor
村田毅
河田發夫
新妻諭
原聰亮
羽田樹人
島田英輝
田中浩
三尾俊之
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1203943A1 publication Critical patent/HK1203943A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
HK15104398.3A 2012-04-24 2015-05-11 Quinazolinedione derivative HK1203943A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012098954 2012-04-24
PCT/JP2013/062006 WO2013161853A1 (fr) 2012-04-24 2013-04-24 Dérivé de quinazolinedione

Publications (1)

Publication Number Publication Date
HK1203943A1 true HK1203943A1 (en) 2015-11-06

Family

ID=49483161

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104398.3A HK1203943A1 (en) 2012-04-24 2015-05-11 Quinazolinedione derivative

Country Status (15)

Country Link
US (1) US9567304B2 (fr)
EP (1) EP2842946B1 (fr)
JP (1) JP6130828B2 (fr)
KR (1) KR20150003849A (fr)
CN (1) CN104379568A (fr)
AR (1) AR090835A1 (fr)
AU (1) AU2013253541A1 (fr)
BR (1) BR112014026305A2 (fr)
CA (1) CA2871453A1 (fr)
HK (1) HK1203943A1 (fr)
MX (1) MX2014012992A (fr)
RU (1) RU2014146993A (fr)
SG (1) SG11201406860SA (fr)
TW (1) TW201348213A (fr)
WO (1) WO2013161853A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR090836A1 (es) 2012-04-24 2014-12-10 Chugai Pharmaceutical Co Ltd Derivados de benzamida
AU2014338070A1 (en) * 2013-10-23 2016-05-05 Chugai Seiyaku Kabushiki Kaisha Quinazolinone and isoquinolinone derivative
WO2016039408A1 (fr) * 2014-09-11 2016-03-17 武田薬品工業株式会社 Composé hétérocyclique
ES2764731T3 (es) 2015-08-31 2020-06-04 Toray Industries Derivado de urea y utilización del mismo
CA2992024A1 (fr) 2015-08-31 2017-03-09 Toray Industries, Inc. Derive d'uree et utilisation associee
WO2018138050A1 (fr) 2017-01-26 2018-08-02 Bayer Aktiengesellschaft Dérivés hétérocycliques bicycliques condensés utilisés comme pesticides
WO2020173860A1 (fr) 2019-02-26 2020-09-03 Bayer Aktiengesellschaft Dérivés hétérocycliques bicycliques condensés utilisés comme pesticides
CN110218193A (zh) * 2019-07-08 2019-09-10 山东大学 3-羟基喹唑啉-2,4(1h,3h)-二酮类衍生物及其制备方法与应用
CN112608282B (zh) * 2019-12-20 2022-07-26 山东先达农化股份有限公司 一种含喹唑啉二酮和n-o结构的化合物及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK570987A (da) 1986-12-01 1988-06-02 Hoffmann La Roche Oxadiazol-, thiadiazol- og triazolforbindelser
JP2751309B2 (ja) 1988-02-16 1998-05-18 三菱化学株式会社 ピラゾール類およびこれを有効成分とする殺虫、殺ダニ、殺菌剤
JPH05255268A (ja) 1992-03-17 1993-10-05 Mitsubishi Kasei Corp ピラゾールカルボキサミド類、これを有効成分とする殺虫、殺ダニ剤および農園芸用殺菌剤
TW225528B (fr) 1992-04-03 1994-06-21 Ciba Geigy Ag
JP3488890B2 (ja) 1993-11-09 2004-01-19 アグロカネショウ株式会社 ３−ｎ−置換キナゾリノン誘導体、その製造法および該化合物を含有する除草剤
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
MXPA00006605A (es) 1999-07-02 2004-12-09 Pfizer Compuestos de carbonil-indol biciclicos como agentes antiinflamatorios/analgesicos.
FR2831536A1 (fr) 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
AU2002352444A1 (en) 2001-12-20 2003-07-09 Celltech R And D Limited Quinazolinedione derivatives
GB0215676D0 (en) 2002-07-05 2002-08-14 Novartis Ag Organic compounds
CN101456841B (zh) 2003-12-25 2012-01-25 日本新药株式会社 酰胺衍生物及医药品
KR100907354B1 (ko) 2004-05-18 2009-07-10 쉐링 코포레이션 Ｐｄｅ4 억제제로서 유용한 치환된 2-퀴놀릴-옥사졸
CN101068777A (zh) 2004-10-08 2007-11-07 万有制药株式会社 硫醚化合物的制备方法
US20090099184A1 (en) 2006-02-16 2009-04-16 Boehringer Ingelheim International Gmbh Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
US20080255161A1 (en) 2007-04-11 2008-10-16 Dmitry Koltun 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
FR2921926B1 (fr) * 2007-10-03 2009-12-04 Sanofi Aventis Derives de quinazolinedione,leur preparation et leurs applications therapeutiques.
WO2009080638A2 (fr) 2007-12-20 2009-07-02 Cellzome Limited Sulfamides en tant qu'inhibiteurs de zap-70
MX2010010272A (es) * 2008-03-19 2011-05-25 Chembridge Corp Nuevos inhibidores de tirosina quinasa.
NZ588909A (en) 2008-04-23 2012-08-31 Takeda Pharmaceutical Iminopyridine derivatives and use thereof
TW201006823A (en) * 2008-07-14 2010-02-16 Novartis Ag Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis
WO2010056230A1 (fr) 2008-10-15 2010-05-20 Cv Therapeutics, Inc. Dérivés de 3-hydroquinazoline-4-one utilisés comme inhibiteurs de stéaryl-acp désaturase
US20100160369A1 (en) 2008-12-04 2010-06-24 Exelixis, Inc. S1P1 Agonists and Methods of Making And Using
CA2777019A1 (fr) * 2009-10-23 2011-04-28 Novartis Ag Procede de traitement de troubles proliferatifs et d'autres etats pathologiques a mediation par une activite kinase de bcr-abl, c-kit, ddr1, ddr2 ou pdgf-r
JO3634B1 (ar) 2009-11-17 2020-08-27 Novartis Ag طريقة لعلاج اضطرابات تكاثرية وحالات مرضية أخرى متوسطة بنشاط كيناز bcr-abl، c-kit، ddr1، ddr2، أو pdgf-r
WO2012054332A1 (fr) 2010-10-18 2012-04-26 Millennium Pharmaceuticals, Inc. Acides hydroxamiques substitués et leurs utilisations
US20140113898A1 (en) 2010-11-08 2014-04-24 Zalicus Pharmaceuticals Ltd. Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
EP2686305B1 (fr) 2011-03-14 2020-09-16 Impact Therapeutics, Inc. Quinazolinediones et leur utilisation
TWI527800B (zh) 2011-04-01 2016-04-01 南京英派藥業有限公司 作為聚（二磷酸腺苷酸－核醣）聚合酶（ｐａｒｐ）之抑制劑之１－（芳基甲基）喹唑啉－２，４（１ｈ，３ｈ）－二酮及其應用
WO2013064083A1 (fr) 2011-11-01 2013-05-10 Impact Therapeutics, Inc. 1-(arylméthyl)-5,6,7,8-tétrahydroquinazoline-2,4-diones et leurs analogues et leur utilisation
AR090836A1 (es) 2012-04-24 2014-12-10 Chugai Pharmaceutical Co Ltd Derivados de benzamida

Also Published As

Publication number Publication date
AR090835A1 (es) 2014-12-10
BR112014026305A2 (pt) 2017-06-27
TW201348213A (zh) 2013-12-01
RU2014146993A (ru) 2016-06-10
WO2013161853A1 (fr) 2013-10-31
SG11201406860SA (en) 2014-11-27
KR20150003849A (ko) 2015-01-09
US20150141400A1 (en) 2015-05-21
US9567304B2 (en) 2017-02-14
MX2014012992A (es) 2015-08-14
EP2842946B1 (fr) 2016-09-28
EP2842946A1 (fr) 2015-03-04
CA2871453A1 (fr) 2013-10-31
CN104379568A (zh) 2015-02-25
EP2842946A4 (fr) 2015-09-09
JPWO2013161853A1 (ja) 2015-12-24
JP6130828B2 (ja) 2017-05-17
AU2013253541A1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
HUS2200040I1 (hu) Benzimidazol-prolin származékok
HK1248702A1 (zh) 取代的吡咯烷-2-甲酰胺
HK1200830A1 (en) Substituted pyrrolidine-2-carboxamides -2-
HK1205740A1 (en) Pyrrolotriazinone derivatives
HK1207375A1 (en) Piperidinylpyrazolopyridine derivative
HK1206724A1 (en) Substituted benzothienopyrimidines
IL236295A (en) The history of indanesulfamide
HK1203943A1 (en) Quinazolinedione derivative
ZA201502175B (en) Oxazolidin-2-one-pyrimidine derivatives
EP2934541A4 (fr) Noribogaïne substituée
HK1206022A1 (zh) 取代的咪唑並噠嗪
HK1200824A1 (en) Substituted phenylazole derivative
PL2873660T3 (pl) Pochodna indolokarboksyamidu
EP2842958A4 (fr) Dérivé de naphthobisthiadiazole
HK1204621A1 (en) 4-alkanoylamino-3-pyrazolone derivative 4--3-